Searched for
PLAVIX
- Brokerages maintain 'hold' on Dr Reddy's post resultsShares of Dr Reddy’s Laboratories (DRL) were down on profit booking after the company disappointed the street with its quarterly results ye...20 Jul, 2012, 01.30 PM IST
- Indian drug outlook favourable: ICRA & Moody'sAccording to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of v...20 Jun, 2012, 06.52 PM IST
- Indian pharma companies like Ranbaxy, Dr Reddy’s & others eye $1bn generic opportunityIn the wake of patent expiries on three blockbuster drugs over the last six-seven months, an opportunity worth nearly $1.3 billion is up fo...13 Jun, 2012, 10.46 AM IST
- Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US marketDr Reddy's Laboratories announced today that it has launched Clopidogrel tablets, USP, a bioequivalent generic version of Plavix in the US ...18 May, 2012, 06.20 PM IST
- Dr Reddy's, Sun Pharma get USFDA nod for heart disease drugDr Reddy's said it has launched clopidogrel tablets in the American market today after receiving approval from the US Food and Drug Adminis...18 May, 2012, 03.00 PM IST
- French pharma giant Sanofi Aventis lines up $300 million for Shantha facility in HyderabadThe company will continue to reduce its reliance on big products such as Plavix, which is the world’s second-best-selling drug with 2010 sa...06 Oct, 2011, 04.47 AM IST
- Biotech drugs to replace chemical entities Lipitor & Plavix as market leadersThe global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.26 Nov, 2010, 09.39 AM IST
- Sanofi-Aventis scans India for acquisitionsSanofi-Aventis which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to fin...26 Sep, 2009, 03.25 AM IST
- Bristol-Myers to shut half of its plants in 3 yearsApart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...07 Dec, 2007, 01.11 AM IST
- Plavix copies hit Sanofi-Aventis, net drops 12%Sanofi-aventis reported a 12% drop in third-quarter profit on Tuesday, citing the loss of top-selling blood thinner Plavix to generic compe...01 Nov, 2006, 12.37 AM IST
- Schering-Plough, Sanofi set sights on Bristol-MyersBristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...18 Sep, 2006, 12.46 AM IST
- Drugmakers eye Bristol-MyersSeveral of the world’s top drugmakers may weigh acquiring Bristol-Myers Squibb after it fired its chief executive, although suitors seem un...15 Sep, 2006, 01.50 AM IST
- Bristol-Myers CEO Dolan gets the axeBristol-Myers Squibb said on Tuesday that chief executive Peter Dolan will step down immediately, and that his post will be filled on an in...13 Sep, 2006, 12.45 AM IST
- Bristol-Myers CEO in hot seat as board meet nearsPeter Dolan, Bristol-Myers Squibb’s embattled chief, spent his summer vacation in France cycling 350 miles in five days.12 Sep, 2006, 12.16 AM IST
- Dr Reddy's may land a major role in Plavix patent playWith the block-the-sale request filed by Bristol-Myers Squibb (BMS) and partner Sanofi-Aventis against Apotex’s brazen launch of generic ‘P...18 Aug, 2006, 12.43 AM IST
- A twist in the patent taleGeneric drugmaker has stunned the pharma world by coming out with a generic version of Plavix,.10 Aug, 2006, 12.58 AM IST
- Plavix Accord: Bristol-Myers, Sanofi face criminal probeSanofi-Aventis said the US started a criminal probe of a plan to keep a generic version of their top-selling blood-thinner Plavix off the m...29 Jul, 2006, 12.25 AM IST
Load More- Brokerages maintain 'hold' on Dr Reddy's post results
